WASHINGTON, Sept. 7, 2011 /PRNewswire-USNewswire/ — The
Generic Pharmaceutical Association (GPhA), which represents the
world’s leading generic drug manufacturers and suppliers, today
announced that it has named Ralph G. Neas as the Association’s new
President and Chief Executive Officer, effective September 12,
2011.
Neas joins GPhA from the National Coalition on Health Care
(NCHC), the nation’s oldest and most diverse health care coalition,
where he has served as President and CEO and led the group’s
efforts to assure quality care, improve the health status of
Americans and control costs in the U.S. health care system. GPhA
intends to introduce Neas to stakeholders throughout September with
an aggressive outreach effort to maximize the industry’s message
and renew its participation as an active and engaged member of the
health care debate.
“As those in Washington and across the country continue to look
for savings in our health care system, it is clear that the greater
use of generic medications is a safe and effective way to reduce
costs while providing patients with the same quality care they have
come to rely on,” Paul Bisaro, President and CEO of Watson
Pharmaceuticals and Chairman of the GPhA Board of Directors
said.
“Ralph is a proven national leader and consensus builder who has
made a career out of working with Republicans and Democrats to
forge coalitions that produce pragmatic compromises to advance the
best interests of the country. He will provide GPhA with an
unprecedented opportunity to expand our message so that any
discussion about reducing health care costs — whether on
Capitol Hill, in state legislatures, the media or anywhere else
— is a discussion that recognizes the billions of dollars in
savings generic medications can contribute in this challenging
economic climate.”
Over the past three years, Neas has worked closely with the
generic pharmaceutical industry. As Pres
‘/>”/>
